Nanoparticles are emerging as powerful tools for research, therapeutic, and diagnostic applications and their utility as lateral flow test probes has gained prominence in recent years. As the need for more sensitive tests increases, new types of nanoparticles are being investigated and incorporated into lateral flow assays. In response, scientists at Fortis Life Sciences have developed nanoshell reporter particles, comprised of a silica core and gold shell, and recent results show their capability to significantly improve the sensitivity of some assays by enhancing the visual contrast generated by each probe and analyte binding event.
Presented by
Jeff Hurst,
Product Manager
Jeff earned his B.S. in Chemistry from University of Washington in 2010 with a focus on electro-optics and is currently the Product Manager for the diagnostics division of Fortis Life Sciences. Prior to joining Fortis Life Sciences, Jeff held roles as a trace organics chemist, sales representative for solid phase extraction consumables, and technical sales lead for RF components in the aviation, defense, and telecom industries.
